-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
August 05, 2010 - Based on
the data items that we will extract (see section III.2.A) we will calculate summary
descriptive
-
effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
December 01, 2019 - For studies amenable to pooling with meta-analyses, we will calculate a weighted mean difference using … a random effects model with the DerSimonian and Laird formula for continuous outcomes. 37 We will calculate
-
effectivehealthcare-admin.ahrq.gov/products/insulin-blood-sugar-2010/research-protocol
December 01, 2019 - For continuous outcomes, we will calculate a weighted mean difference by using a random-effects model … with the DerSimonian and Laird formula. 29 For dichotomous outcomes, we will calculate a pooled effect
-
effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
December 01, 2019 - For continuous outcomes, we will calculate a weighted mean difference by using a random-effects model … with the DerSimonian and Laird formula. 9 For dichotomous outcomes, we will calculate a pooled effect
-
effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol
January 01, 2021 - For binary outcomes (e.g., adverse events), we will calculate risk differences between groups or risk … To assess statistical heterogeneity, we will calculate the chi-squared statistic and the I 2 statistic
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
March 01, 2023 - Core Team; or
· ≥ $5,000 for Partners, Key Informants, TEP members, Invited Peer Reviewers
To calculate … Team; or
· ≥ $5,000 for Partners, Key Informants, TEP members, Invited Peer Reviewers
To calculate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
January 27, 2012 - For binary outcomes
(e.g., adverse events), we will calculate risk differences between groups or
risk … To assess statistical heterogeneity, we will calculate the chi-squared statistic
and the I2 statistic
-
effectivehealthcare-admin.ahrq.gov/products/heart-failure-transition-care/policymaker
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - comparisons were statistically significant
and did not provide patient numbers, precluding our
ability to calculate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
November 01, 2012 - Furthermore, variability in the definitions of outcomes
required us to calculate standardized mean differences
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - 1
Comparative Effectiveness Review
Number 74
Progestogens for Prevention
of Preterm Birth
Executive Summary
Introduction
Burden of Preterm Birth
Birth before completion of 37 weeks of
pregnancy is considered preterm. These
early births are associated with more
than 85 percent of all perinatal morbidity
an…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pressure-ulcer-treatment_research-protocol.pdf
November 08, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 8, 2011
Evidence-based Practice Center Systematic Review Protocol
Pressure Ulcer Treatment Strategies: A Comparative Effectiveness Review
I. Background and Objectives for t…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review
Comparative Effectiveness Review
Number 273
Treatment of Stages I–III Squamous
Cell Anal Cancer: A Systematic Review
Executive Summary
Main Points
• For the ini…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Purpose of Review
To assess adverse events of antidepressants in the
treatment of major depressive disorder in adults 65 years
of age or older.
Key Messages
In people 65 years of age or older:
• Serotoni…
-
effectivehealthcare-admin.ahrq.gov/products/transparency-mental-health/research
December 01, 2020 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/pressure-ulcer-treatment/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - For studies amenable to pooling with meta-analyses, we will calculate a weighted mean
difference using … a random effects model with the DerSimonian and Laird formula for
continuous outcomes.37 We will calculate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
May 31, 2017 - If studies directly compare two measures and
report differences in AUROCs, we will calculate pooled … or
tests of differences
in means) will be
excluded unless data
is provided that can
be used to calculate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - transit time
Any Prospective
enrolled,
blinded review,
with
confirmatory
second reviewer
to calculate … analysis based
on above data
to determine
optimal
thresholds,
would need
data from other
trials to
calculate … transit time
Any Prospective
enrolled, blinded
review, with
confirmatory
second reviewer
to calculate … analysis based
on above data
to determine
optimal
thresholds,
would need
data from other
trials to
calculate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - 1
Comparative Effectiveness Review
Number 120
Treatments for Seasonal Allergic Rhinitis
Executive Summary
Background
Seasonal allergic rhinitis (SAR), also
known as hay fever, is an allergic reaction
in the upper airways that occurs when
sensitized individuals encounter airborne
allergens (typically tree, gras…